FIDAM GMBH
Desconocido
MuSiC4Diabetes: Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabe...
FIDAM GMBH
participó en un
HORIZON EUROPE:
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01
It will be a radically new approach for long-term continuous monitoring of insulin-treated persons with diabetes (ITD) moving from a glucose...
2023-06-21 - 2027-09-30 | Financiado
2023-06-21 - 2027-09-30 | Financiado
* No se disponen de datos de la empresa actual.